Literature DB >> 7935611

A recombinant Trypanosoma cruzi trans-sialidase lacking the amino acid repeats retains the enzymatic activity.

O E Campetella1, A D Uttaro, A J Parodi, A C Frasch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7935611     DOI： 10.1016/0166-6851(94)00036-0

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  11 in total

1.  trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease.

Authors:  A S Buchovsky; O Campetella; G Russomando; L Franco; R Oddone; N Candia; A Luquetti; S M Gonzalez Cappa; M S Leguizamon
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.

Authors:  Romina P Muiá; Hai Yu; Jennifer A Prescher; Ulf Hellman; Xi Chen; Carolyn R Bertozzi; Oscar Campetella
Journal:  Glycobiology       Date:  2010-03-30       Impact factor: 4.313

4.  Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.

Authors:  Juan Mucci; Alejandra Hidalgo; Esteban Mocetti; Pablo F Argibay; M Susana Leguizamon; Oscar Campetella
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Use of trans-Sialidase inhibition assay in a population serologically negative for Trypanosoma cruzi but at a high risk of infection.

Authors:  M S Leguizamón; G Russomando; A Rojas de Arias; M Samudio; M Cabral; S M González-Cappa; A C Frasch; O Campetella
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

6.  Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity.

Authors:  M S Leguizamón; O E Campetella; S M González Cappa; A C Frasch
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 7.  Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.

Authors:  Oscar Campetella; Carlos A Buscaglia; Juan Mucci; María Susana Leguizamón
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-20       Impact factor: 5.187

Review 8.  Modulation of Cell Sialoglycophenotype: A Stylish Mechanism Adopted by Trypanosoma cruzi to Ensure Its Persistence in the Infected Host.

Authors:  Leonardo Freire-de-Lima; Leonardo M da Fonseca; Vanessa A da Silva; Kelli M da Costa; Alexandre Morrot; Célio G Freire-de-Lima; Jose O Previato; Lucia Mendonça-Previato
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

9.  Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells.

Authors:  Daniela A Bermejo; Shaun W Jackson; Melisa Gorosito-Serran; Eva V Acosta-Rodriguez; Maria C Amezcua-Vesely; Blythe D Sather; Akhilesh K Singh; Socheath Khim; Juan Mucci; Denny Liggitt; Oscar Campetella; Mohamed Oukka; Adriana Gruppi; David J Rawlings
Journal:  Nat Immunol       Date:  2013-04-07       Impact factor: 25.606

10.  Rab11 regulates trafficking of trans-sialidase to the plasma membrane through the contractile vacuole complex of Trypanosoma cruzi.

Authors:  Sayantanee Niyogi; Juan Mucci; Oscar Campetella; Roberto Docampo
Journal:  PLoS Pathog       Date:  2014-06-26       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.